American Oriental Bioengineering Revenue, Profits - AOBI Annual Income Statement

Add to My Stocks
$2.5 $0 (0%) AOBI stock closing price Sep 20, 2018 (Closing)

AOBI stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the American Oriental Bioengineering stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $145.09M for 2012 impacts the AOBI stock. Investors typically check year over year or quarter over quarter revenue growth. The American Oriental Bioengineering profit and loss statement for 2012 shows a net profit of $-59.71M. Profits for last year was $-67.44M. Apart from this an investor should also check American Oriental Bioengineering assets and American Oriental Bioengineering free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20122011201020092008
American Oriental Bioengineering Revenues or Net Sales
145.09M212.69M305.94M296.15M264.64M
Cost Of Goods Sold (COGS)100.74M112.93M148.18M129.36M91.03M
American Oriental Bioengineering Gross Profit
44.35M99.75M157.75M166.78M173.61M
Research & Development Expense6.24M12.65M15.36M7.92M12.25M
Selling General & Admin Expense117.19M122.71M105.36M94.06M92.64M
Income Before Depreciation Depletion Amortization-79.08M-35.62M37.03M64.79M68.71M
Depreciation Depletion Amortization7.24M7.49M6.66M6.03M4.38M
Non Operating Income34.66M-18.13M--4.24M-1.22M
Interest Expense5.83M6.61M5.9M-2.57M
American Oriental Bioengineering Pretax Income
-57.5M-67.85M24.64M54.51M60.53M
Provision for Income Taxes2.22M-8.33M13.21M12.72M
MinorityInterest-0.01M-1.04M-0.02M-0.11M-
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-59.72M-68.49M16.31M41.3M47.8M
Extraordinary Items & Discontinued Operations-----
American Oriental Bioengineering Profit/ Loss (Net Income)
-59.71M-67.44M16.34M41.42M47.8M
Average Shares used to compute Diluted EPS-----
Average Shares used to compute Basic EPS-----
Income Before Nonrecurring Items-65.22M-16.34M42.99M62.7M
Income from Nonrecurring Items5.51M---1.57M-14.89M
American Oriental Bioengineering Earnings Per Share Basic Net
-780.00-859.80220.00560.00620.00
American Oriental Bioengineering Earnings Per Share Diluted Net
-780.00-220.00530.00610.00
EPS Diluted Before Nonrecurring Items-850.00-220.00550.00760.00
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on American Oriental Bioengineering stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: American Oriental Bioengineering revenue chart implies that the company is growing. It has not been the case with American Oriental Bioengineering. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-59.71M for American Oriental Bioengineering for 2012. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the AOBI income statement, one can check the American Oriental Bioengineering historical stock prices to check how the price has moved with time.

American Oriental Bioengineering Income Statement - Key Financial Ratios

Annual Income Statements - American Oriental Bioengineering, Inc. Industry Peers

Biostar Pharma income statement, Lotus Pharma income statement, Vertical Health income statement